Haemonetics announced today that it has completed its previously announced sale of its whole blood assets to GVS S.p.A.

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has completed the ...

Haemonetics Corp. engages in the development ... The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

BOSTON, Jan. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San ...

In a report released today, Joanne Wuensch from Citi maintained a Hold rating on Haemonetics (HAE – Research Report). The company’s shares ...

In a report released today, Marie Thibault from BTIG maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target ...

BOSTON, Jan. 14, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...